Impact of Primary Percutaneous Coronary Intervention on Complete Atrioventricular Block With Acute Inferior ST-Elevation Myocardial Infarction.

Autor: Malik J; Cardiology, Rawalpindi Institute of Cardiology, Rawalpindi, PAK., Laique T; Pharmacology, Lahore Medical and Dental College, Lahore, PAK., Farooq MH; Internal Medicine, Ysbyty Gwynedd Hospital, Bangor, GBR., Khan U; Pulmonary Medicine, University Hospital Limerick, Limerick, IRL., Malik F; Internal Medicine, Blackpool Teaching Hospitals National Health Service Foundation Trust, Blackpool, GBR., Zahid M; Family Medicine, Sherbourne Medical Center, Sherbourne, GBR., Majid A; Paediatrics and Child Health, Aukland City Hospital, Aukland, NZL.
Jazyk: angličtina
Zdroj: Cureus [Cureus] 2020 Aug 25; Vol. 12 (8), pp. e10013. Date of Electronic Publication: 2020 Aug 25.
DOI: 10.7759/cureus.10013
Abstrakt: Background and aims Complete atrioventricular block (CAVB) is associated with poor clinical outcomes in ST-elevation myocardial infarction (STEMI). This study determined the frequency and outcomes of primary percutaneous coronary intervention (PPCI) in patients with CAVB with acute inferior STEMI. Methods We conducted an observational, prospective study and enrolled 151 patients who were diagnosed with inferior STEMI. All patients received PPCI. The clinical outcomes were compared in patients with and without CAVB. The data was recorded on a collection form and analyzed on Statistical Package for Social Sciences (SPSS) software. Descriptive statistics were applied. For quantitative variables, standard deviation and mean were obtained, and statistical tests were also applied. Results Baseline characteristics were homogeneous in all patients. Half of the study population was either diabetic or hypertensive. Out of 151 participants, 21 (13.9%) developed CAVB. Two-thirds of the patients, who had developed heart block, reverted after PPCI. After a follow-up of two weeks, in-hospital mortality did not differ between the groups. Conclusion We conclude that PPCI can improve outcomes of CAVB-complicated acute inferior STEMI and suggest that primary PCI should be the preferred reperfusion therapy in patients with CAVB with STEMI.
Competing Interests: The authors have declared that no competing interests exist.
(Copyright © 2020, Malik et al.)
Databáze: MEDLINE